Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-04 PET for Rectal Cancer Response Evaluation
NCT05999227Unknown
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 68Ga-FAPI-4 in rectal cancer. Primary endpoints: 68Ga-FAPI-04 PET Imaging Analysis and 18F-FDG PET Imaging Analysis. Status: unknown.
02
Drugs
68Ga-FAPI-4
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT05999227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05999227.